BeiGene, Ltd. (ONC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $322.37
• Market Cap: $38.98B
• P/E Ratio: 664.59
• EPS: $0.53
• 52-Week High: $385.22
• 52-Week Low: $196.45

Market Sentiment

BeiGene, Ltd. currently has a Bullish sentiment score of 0.18.

About BeiGene, Ltd.

BeiGene, Ltd. (Ticker: ONC) is a pioneering global biotechnology company focused on advancing cancer treatment through innovative drug discovery and development. With a robust presence in key markets, including the United States, China, and Europe, BeiGene is dedicated to addressing critical unmet needs in oncology. The company's extensive pipeline of proprietary therapies, complemented by strategic collaborations, underscores its commitment to precision medicine and enhancing patient outcome...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BeiGene, Ltd. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ONC pay dividends?

BeiGene, Ltd. (ONC) does not currently pay a regular dividend.

What is ONC's P/E ratio?

BeiGene, Ltd. has a price-to-earnings (P/E) ratio of 664.59.

What is ONC's market cap?

BeiGene, Ltd. (ONC) has a market capitalization of $38.98B with a current stock price of $322.37.